Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer Patients
| Autor: | Moretto, Roberto, Rossini, Daniele, Capone, Iolanda, Boccaccino, Alessandra, Perrone, Federica, Tamborini, Elena, Masi, Gianluca, Antoniotti, Carlotta, Marmorino, Federica, Conca, Veronica, Borelli, Beatrice, Martignetti, Angelo, Pecora, Irene, Simionato, Francesca, Cupini, Samanta, Ambrosini, Margherita, Manca, Paolo, Pietrantonio, Filippo, Falcone, Alfredo, Cremolini, Chiara |
|---|---|
| Zdroj: | In Clinical Colorectal Cancer December 2021 20(4):314-317 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect